USPTO trademark

OPSYNVI

RegisteredUSPTOWord markClass 5

"OPSYNVI" is a word mark owned by Actelion Pharmaceuticals Ltd, filed at the USPTO on September 8, 2020. It is registered and covers class 5 (Pharmaceuticals).

View Actelion Pharmaceuticals Ltd portfolioGet this data via the API
Official USPTO record
OPSYNVI trademark as filed
As filed with the USPTO
Status
Registered
Since January 2, 2024
Filed
September 8, 2020
Registered
January 2, 2024
Expires
Not recorded
Application no.
90165717
Registration no.
7257052
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns OPSYNVI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Actelion Pharmaceuticals Ltd

Allschwil, Switzerland

428 trademarks in the portfolioView company

Representative

Cheryl Foytlin

Johnson & Johnson

Goods and services

What the mark covers

The products and services OPSYNVI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. 1(b) basis deleted; new basis requested
  7. Jurisdiction restored to examining attorney
  8. Petition to director - change basis - granted
  9. Assigned to petition staff
  10. Notice of allowance cancelled

10 earlier steps on the official record.

FAQ

About OPSYNVI

Who owns the trademark "OPSYNVI"?

The USPTO trademark "OPSYNVI" (application 90165717) is owned by Actelion Pharmaceuticals Ltd.

What is the status of "OPSYNVI"?

Its status at the USPTO is: registered.

When was "OPSYNVI" registered?

It was registered on January 2, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OPSYNVI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2c34-bc73-7468-a078-1a1dcf98da1d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c34-bc73-7468-a078-1a1dcf98da1d",
  "object": "trademark",
  "mark_text": "OPSYNVI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90165717",
  "filing_date": "2020-09-08",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Actelion Pharmaceuticals Ltd",
      "entity_id": "ent_019eb702-a943-779f-b91a-3034519ba72d"
    }
  ]
}